aol.com
Cure8 news brief
Why This Matters
Perioperative nutrition could affect recovery after Crohn’s bowel surgery; a trial of Exclusive Enteral Nutrition may show whether a pre- or peri-surgical liquid diet reduces complications and improves outcomes. Patients and clinicians may want to follow results to inform pre-surgery care planning.
Who Should Pay Attention
Adults with Crohn’s disease considering or scheduled for bowel surgery; colorectal surgeons and perioperative dietitians; researchers interested in nutrition interventions for IBD.
Study Snapshot
Story typeMainstream News
Evidence typePhase 2 clinical trial
Source depthFull source text
What To Know
This article reports on a trial being run by University Hospitals Sussex NHS Foundation Trust with the University of Birmingham to evaluate EEN alongside bowel surgery for Crohn’s disease. It does not present trial results or detailed methods such as eligibility criteria, duration of the EEN programme, or specific outcomes being measured.
If you are considering nutritional strategies before surgery, discuss options with your surgical and nutrition teams — this article is a news report about a trial, not clinical guidance.
Keep In Mind
This is a news report about a trial being run in the UK; the article does not present results or detailed study methods. Anecdotal patient experience is included but should not be interpreted as evidence of efficacy.
Source Details
Review the original publication for the complete reporting, methods, and context.
Publicationaol.com
Indexed viaGoogle News
Source typeWeb article
PublishedJul 19, 2026, 11:41 AM
Content availableFull source text
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
New research looks at GLP-1's to treat gastrointestinal diseases
GLP-1 drugs are being studied as possible treatments for gut conditions beyond weight loss—researchers are exploring whether they can reduce gut inflammation or improve related liver disease. Patients with IBD, IBS, or...
Crohn's Disease Clinical Trials And Studies 2025: EMA, PDMA, FDA Approvals, Mechanism ...
This roundup highlights many drugs and trials in development for Crohn’s disease, including late‑stage studies of biologics and newer oral agents — information that could affect future treatment options. Patients on...
UC physician-researcher's work yields landmark five-year data for Crohn's disease drug
Long-term data help patients and clinicians understand whether a biologic maintains benefit and safety over years. Sustained clinical remission and endoscopic healing are important outcomes linked to better long-term...